Researchers will evaluate if the drug rapamycin can reverse the negative heart changes associated with subvalvular aortic stenosis, the most common congenital heart defect in dogs.
Researchers will look for a shared genetic origin of hypertrophic cardiomyopathy, the most diagnosed feline heart disease, across breeds and mixed breeds.
Researchers will look for a shared genetic origin of hypertrophic cardiomyopathy, the most diagnosed feline heart disease, in the general cat population.
Researchers will use novel gene-editing tools to correct damaging mutations in heart cells to help advance gene therapies for dilated cardiomyopathy, a common canine heart disease.
Researchers will study circulating proteins and DNA in cats with known heart disease and clot complications and develop a screening test to help monitor disease risk for early intervention.